Business Wire

Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...
Healio

FDA clears wearable insulin pod for adults with type 2 diabetes using basal insulin

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The FDA has cleared the Omnipod Go for use by adults ...
Monthly Prescribing Reference

Basal-Only Insulin Delivery System Cleared for Patients With Type 2 Diabetes

Credit: Insulet. Omnipod GO is a tubeless and waterproof insulin delivery system. The Food and Drug Administration (FDA) has cleared the Omnipod GO ™ insulin delivery device for individuals 18 years ...
Healio

Adults with type 2 diabetes see glycemic benefits with automated insulin delivery

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. In a small feasibility study, adults with type 2 ...
Nasdaq

Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes

“Omnipod GO was designed to serve the more than three million people using basal insulin or transitioning to insulin therapy to treat their type 2 diabetes,” said Jim Hollingshead, President and Chief ...